Follow
Julien Olivet, MS, PhD
Julien Olivet, MS, PhD
Postdoctoral Researcher at Rega Institute, KU Leuven
Verified email at mailfence.com
Title
Cited by
Cited by
Year
Maximizing binary interactome mapping with a minimal number of assays
SG Choi, J Olivet, P Cassonnet, PO Vidalain, K Luck, L Lambourne, ...
Nature communications 10 (1), 3907, 2019
582019
The HTLV-1 viral oncoproteins Tax and HBZ reprogram the cellular mRNA splicing landscape
C Vandermeulen, T O’grady, J Wayet, B Galvan, S Maseko, M Cherkaoui, ...
PLoS pathogens 17 (9), e1009919, 2021
252021
Alternative glycosylation controls endoplasmic reticulum dynamics and tubular extension in mammalian cells
D Kerselidou, BS Dohai, DR Nelson, S Daakour, N De Cock, ...
Science advances 7 (19), eabe8349, 2021
92021
A systematic approach to identify host targets and rapidly deliver broad-spectrum antivirals
J Olivet, SB Maseko, AN Volkov, K Salehi-Ashtiani, K Das, ...
Molecular Therapy 30 (5), 1797-1800, 2022
62022
AI-guided pipeline for protein–protein interaction drug discovery identifies a SARS-CoV-2 inhibitor
P Trepte, C Secker, J Olivet, J Blavier, S Kostova, SB Maseko, I Minia, ...
Molecular Systems Biology 20 (4), 428-457, 2024
32024
Identification of small molecule antivirals against HTLV-1 by targeting the hDLG1-Tax-1 protein-protein interaction
SB Maseko, Y Brammerloo, I Van Molle, A Sogues, C Martin, C Gorgulla, ...
Antiviral research 217, 105675, 2023
22023
A quantitative mapping approach to identify direct interactions within complexomes
P Trepte, C Secker, SG Choi, J Olivet, ES Ramos, P Cassonnet, S Golusik, ...
bioRxiv, 2021.08. 25.457734, 2021
22021
Expanding the HDAC druggable landscape beyond enzymatic activity
J Olivet, SG Choi, S Sierra, TM O'Grady, M de la Fuente Revenga, F Laval, ...
bioRxiv, 2023
12023
Interactome and structural basis for targeting the human T-cell leukemia virus Tax oncoprotein
SB Maseko, I Van Molle, K Blibek, C Gorgulla, J Olivet, J Blavier, ...
bioRxiv, 2021.08. 25.457680, 2021
12021
The viral oncoproteins Tax and HBZ reprogram the cellular mRNA splicing landscape
C Vandermeulen, T O’Grady, B Galvan, M Cherkaoui, A Desbuleux, ...
bioRxiv, 2021.01. 18.427104, 2021
12021
AI-guided pipeline for protein-protein interaction drug discovery identifies a SARS-CoV-2 inhibitor (preprint)
P Trepte, C Secker, S Kostova, SB Maseko, SG Choi, J Blavier, I Minia, ...
2023
Selective disruption of histone deacetylase complexes by small-molecule inhibitors of protein interactions
J OLIVET
University of Liège, Belgium, 2021
2021
Structural basis for targeting the human T-cell leukemia virus Tax oncoprotein and syntenin-1 interaction using a small molecule
S Maseko, I Van Molle, K Blibek, C Gorgulla, J Olivet, J Blavier, ...
2021
Exostosin-1 Glycosyltransferase Regulates Endoplasmic Reticulum Architecture and Dynamics
D Kerselidou, BS Dohai, DR Nelson, S Daakour, N De Cock, DK Kim, ...
bioRxiv, 2020.09. 02.275925, 2020
2020
Systematic assessment of druggable cavities in a histone deacetylase complex
J Olivet
Keystone Symposium, Phenotypic Drug Discovery: Recent Advances and Insights …, 2019
2019
Design and optimization of assays to detect protein-protein interactions
J Olivet
Master internship Report, Harvard Medical School & Dana-Farber Cancer …, 2015
2015
Synthesis of an alginate/SiO2-TiO2 hybrid material suitable for animal cell encapsulation: towards the design of a transplantable artificial organ for use in new cell therapy …
J OLIVET
Université de Namur, Belgium, 2015
2015
The system can't perform the operation now. Try again later.
Articles 1–17